Targeting Mechanisms for Natural Killer Cell Dysfunction in Patients with Multiple Myeloma

被引：0
|
作者：
Jenkins, Misty [1 ]
Canfield, Rachael [1 ]
Robbins, Michael [2 ]
Ritchie, David S. [3 ]
Trapani, Joe [1 ]
Neeson, Paul [4 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
[4] Peter MacCallum Canc Ctr, Canc Immunol Res, Melbourne, Vic, Australia
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Myeloma Can Modulate Expanded Natural Killer Cell Function Through Multiple Mechanisms
    Garg, Tarun K.
    Khan, Junaid
    Stivers, Justin
    Szmania, Susann
    Greenway, Amy D.
    Lingo, Joshuah D.
    Stone, Katie
    Woods, Emily
    Barlogie, Bart
    Epstein, Joshua
    van Rhee, Frits
    BLOOD, 2012, 120 (21)
  • [2] Natural killer cell alloreactive haploidentical stem cell transplantation for multiple myeloma patients
    Elssen, Catharina
    Wieten, Lotte
    Von dem Borne, Peter
    Meijer, Ellen
    Bos, Gerard
    BONE MARROW TRANSPLANTATION, 2019, 54 : 605 - 605
  • [3] NATURAL-KILLER CELL-ACTIVITY IN PATIENTS WITH MULTIPLE-MYELOMA
    OGMUNDSDOTTIR, HM
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 133 - 143
  • [4] Amelioration of natural killer cell function driven by invariant natural killer T cell activation in multiple myeloma
    Yamasaki, Satoru
    Iyoda, Tomonori
    Hidaka, Michihiro
    Kawano, Fumio
    Abe, Yu
    Suzuki, Kenshi
    Kadowaki, Norimitsu
    Shimizu, Kanako
    Fujii, Shin-ichiro
    CANCER SCIENCE, 2018, 109 : 109 - 109
  • [5] Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
    Catharina Van Elssen
    Gwendolyn van Gorkom
    Christine Voorter
    Peter von dem Borne
    Ellen Meijer
    Lotte Wieten
    Gerard Bos
    Annals of Hematology, 2021, 100 : 181 - 187
  • [6] Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
    Van Elssen, Catharina
    van Gorkom, Gwendolyn
    Voorter, Christine
    von Dem Borne, Peter
    Meijer, Ellen
    Wieten, Lotte
    Bos, Gerard
    ANNALS OF HEMATOLOGY, 2021, 100 (01) : 181 - 187
  • [7] Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities
    Bisht, Kamlesh
    Merino, Aimee
    Igarashi, Rob
    Gauthier, Laurent
    Chiron, Marielle
    Desjonqueres, Alexandre
    Smith, Eric
    Briercheck, Edward
    Romee, Rizwan
    Alici, Evren
    Vivier, Eric
    O'Dwyer, Michael
    van de Velde, Helgi
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [8] Functional Genomic Landscape of Natural Killer Cell Evasion in Multiple Myeloma
    Gandolfi, Sara
    Dufva, Olli
    Huuhtanen, Jani
    Dashevsky, Olga
    Klievink, Jay
    Bouhlal, Jonas
    Sheffer, Michal
    Kankainen, Matti
    Simoes, Ricardo De Matos
    Mustjoki, Satu
    Mitsiades, Constantine S.
    BLOOD, 2021, 138
  • [9] Natural killer cell immunotherapy against multiple myeloma: Progress and possibilities
    Liu, Pan
    Jin, Yanxia
    Sattar, Haseeb
    Liu, Hailing
    Xie, Weiling
    Zhou, Fuling
    JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 103 (05) : 821 - 828
  • [10] Targeting Caveolin-1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell-Mediated Immunotherapy
    Zhan, Dewen
    Du, Zhimin
    Zhang, Shang
    Huang, Juanru
    Zhang, Jian
    Zhang, Hui
    Liu, Zhongrui
    Menu, Eline
    Wang, Jinheng
    ADVANCED SCIENCE, 2025, 12 (04)
12345